News > India approves Covaxin, Covishield for emergency use
India approves Covaxin, Covishield for emergency use
Rediff.com | 03/01/2021 01:54 PM | Click to read full article
India's drugs regulator on Sunday approved Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use in the country, paving the way for a massive inoculation drive.
The Serum Institute of India, the world's largest vaccine manufacturer, has tied up with AstraZeneca to manufacture Covishield.
